| 0 |
Decorporation Agent [EPC] |
2 |
0.4000 |
| 1 |
Potassium Binder [EPC] |
2173 |
0.1450 |
| 2 |
Polyene Antimicrobial [EPC] |
50 |
0.1256 |
| 3 |
Stimulant Laxative [EPC] |
1591 |
0.1123 |
| 4 |
Vitamin K [EPC] |
443 |
0.1047 |
| 5 |
mu-Opioid Receptor Agonist [EPC] |
283 |
0.0967 |
| 6 |
Polymyxin-class Antibacterial [EPC] |
6 |
0.0857 |
| 7 |
Peroxisome Proliferator-activated Receptor Agonist [EPC] |
58 |
0.0780 |
| 8 |
Intestinal Lipase Inhibitor [EPC] |
1992 |
0.0773 |
| 9 |
Guanylate Cyclase-C Agonist [EPC] |
2133 |
0.0754 |
| 10 |
Cholinergic Muscarinic Agonist [EPC] |
157 |
0.0752 |
| 11 |
Calcitonin Gene-related Peptide Receptor Antagonist [EPC] |
453 |
0.0690 |
| 12 |
Chloride Channel Activator [EPC] |
581 |
0.0618 |
| 13 |
Photoactivated Radical Generator [EPC] |
7 |
0.0569 |
| 14 |
Amino Acid Hypertonic Solution [EPC] |
8 |
0.0559 |
| 15 |
Nuclear Export Inhibitor [EPC] |
452 |
0.0525 |
| 16 |
Protease Activator [EPC] |
4 |
0.0519 |
| 17 |
Serotonin-4 Receptor Agonist [EPC] |
31 |
0.0502 |
| 18 |
Progestin Antagonist [EPC] |
227 |
0.0483 |
| 19 |
Non-Standardized Plant Allergenic Extract [EPC] |
833 |
0.0478 |
| 20 |
Cortisol Synthesis Inhibitor [EPC] |
31 |
0.0447 |
| 21 |
Catechol-O-Methyltransferase Inhibitor [EPC] |
315 |
0.0442 |
| 22 |
Thyroid Hormone Receptor beta Agonist [EPC] |
81 |
0.0428 |
| 23 |
l-Thyroxine [EPC] |
2 |
0.0417 |
| 24 |
Osmotic Diuretic [EPC] |
214 |
0.0416 |
| 25 |
Hedgehog Pathway Inhibitor [EPC] |
384 |
0.0412 |
| 26 |
Gonadotropin Releasing Hormone Receptor Antagonist [EPC] |
1019 |
0.0409 |
| 27 |
Melanocortin 4 Receptor Agonist [EPC] |
11 |
0.0407 |
| 28 |
l-Triiodothyronine [EPC] |
2 |
0.0400 |
| 29 |
Serotonin-3 Receptor Antagonist [EPC] |
5174 |
0.0391 |
| 30 |
Antidiarrheal [EPC] |
9 |
0.0386 |
| 31 |
Catecholamine Synthesis Inhibitor [EPC] |
3 |
0.0380 |
| 32 |
Aluminum Complex [EPC] |
896 |
0.0376 |
| 33 |
Osmotic Laxative [EPC] |
10803 |
0.0373 |
| 34 |
Non-Standardized Fungal Allergenic Extract [EPC] |
77 |
0.0369 |
| 35 |
Vitamin D3 Analog [EPC] |
738 |
0.0366 |
| 36 |
Non-Standardized Pollen Allergenic Extract [EPC] |
22 |
0.0364 |
| 37 |
GLP-1 Receptor Agonist [EPC] |
15122 |
0.0359 |
| 38 |
Standardized Pollen Allergenic Extract [EPC] |
22 |
0.0357 |
| 39 |
Sucrose-specific Enzyme [EPC] |
6 |
0.0357 |
| 40 |
Influenza A M2 Protein Inhibitor [EPC] |
549 |
0.0357 |
| 41 |
Phenothiazine [EPC] |
1043 |
0.0352 |
| 42 |
Bile Acid Sequestrant [EPC] |
409 |
0.0340 |
| 43 |
beta3-Adrenergic Agonist [EPC] |
1572 |
0.0340 |
| 44 |
Progesterone [EPC] |
761 |
0.0334 |
| 45 |
Aromatic Amino Acid Decarboxylation Inhibitor [EPC] |
952 |
0.0334 |
| 46 |
Estrogen Receptor Antagonist [EPC] |
1320 |
0.0331 |
| 47 |
Complement C5 Inhibitor [EPC] |
3 |
0.0323 |
| 48 |
alpha-Hydroxy Acid [EPC] |
67 |
0.0316 |
| 49 |
Glycolipid Disialoganglioside-directed Antibody [EPC] |
33 |
0.0314 |
| 50 |
Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
605 |
0.0311 |
| 51 |
Dopamine-2 Receptor Antagonist [EPC] |
228 |
0.0300 |
| 52 |
Phosphate Binder [EPC] |
90 |
0.0300 |
| 53 |
Non-Standardized Insect Allergenic Extract [EPC] |
173 |
0.0299 |
| 54 |
RNA Synthetase Inhibitor Antibacterial [EPC] |
396 |
0.0295 |
| 55 |
Standardized Insect Venom Allergenic Extract [EPC] |
210 |
0.0292 |
| 56 |
Non-Standardized House Dust Allergenic Extract [EPC] |
21 |
0.0291 |
| 57 |
Soluble Guanylate Cyclase Stimulator [EPC] |
959 |
0.0287 |
| 58 |
Non-Standardized Food Allergenic Extract [EPC] |
2269 |
0.0286 |
| 59 |
Nitrate Vasodilator [EPC] |
2497 |
0.0285 |
| 60 |
Androgen Receptor Inhibitor [EPC] |
2089 |
0.0285 |
| 61 |
Aromatic Amino Acid [EPC] |
1676 |
0.0280 |
| 62 |
Calcium [EPC] |
4061 |
0.0275 |
| 63 |
Non-narcotic Antitussive [EPC] |
448 |
0.0272 |
| 64 |
Carbamoyl Phosphate Synthetase 1 Activator [EPC] |
20 |
0.0268 |
| 65 |
Provitamin D2 Compound [EPC] |
10264 |
0.0268 |
| 66 |
Thalidomide Analog [EPC] |
13603 |
0.0264 |
| 67 |
Calcitonin [EPC] |
82 |
0.0264 |
| 68 |
Expectorant [EPC] |
5382 |
0.0262 |
| 69 |
Cannabinoid [EPC] |
261 |
0.0261 |
| 70 |
Cholinergic Muscarinic Antagonist [EPC] |
1012 |
0.0261 |
| 71 |
Central alpha-2 Adrenergic Agonist [EPC] |
1466 |
0.0260 |
| 72 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2939 |
0.0258 |
| 73 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
2979 |
0.0257 |
| 74 |
Parenteral Iron Replacement [EPC] |
344 |
0.0255 |
| 75 |
Aromatase Inhibitor [EPC] |
2839 |
0.0254 |
| 76 |
Opioid Agonist [EPC] |
6703 |
0.0250 |
| 77 |
Nonergot Dopamine Agonist [EPC] |
376 |
0.0246 |
| 78 |
Leukotriene Receptor Antagonist [EPC] |
684 |
0.0244 |
| 79 |
GLP-2 Analog [EPC] |
321 |
0.0240 |
| 80 |
Potassium-sparing Diuretic [EPC] |
314 |
0.0236 |
| 81 |
Anticholinergic [EPC] |
422 |
0.0236 |
| 82 |
Parathyroid Hormone Analog [EPC] |
2544 |
0.0227 |
| 83 |
Muscle Relaxant [EPC] |
1027 |
0.0226 |
| 84 |
Standardized Animal Hair Allergenic Extract [EPC] |
19 |
0.0226 |
| 85 |
Nitroimidazole Antimicrobial [EPC] |
1471 |
0.0225 |
| 86 |
Benzodiazepine [EPC] |
15790 |
0.0224 |
| 87 |
Thiazide Diuretic [EPC] |
4699 |
0.0223 |
| 88 |
Plasma Volume Expander [EPC] |
67 |
0.0223 |
| 89 |
Barbiturate [EPC] |
261 |
0.0223 |
| 90 |
Nitrofuran Antibacterial [EPC] |
501 |
0.0220 |
| 91 |
Proteasome Inhibitor [EPC] |
2492 |
0.0220 |
| 92 |
Prostacyclin Receptor Agonist [EPC] |
563 |
0.0219 |
| 93 |
Kinase Inhibitor [EPC] |
10397 |
0.0218 |
| 94 |
Sulfonylurea [EPC] |
2667 |
0.0218 |
| 95 |
Histamine-1 Receptor Antagonist [EPC] |
1800 |
0.0218 |
| 96 |
Carnitine Analog [EPC] |
78 |
0.0217 |
| 97 |
Nicotinic Acid [EPC] |
1337 |
0.0217 |
| 98 |
Non-Standardized Chemical Allergen [EPC] |
1657 |
0.0217 |
| 99 |
Platelet Aggregation Inhibitor [EPC] |
12162 |
0.0216 |
| 100 |
HMG-CoA Reductase Inhibitor [EPC] |
9384 |
0.0215 |
| 101 |
Vitamin C [EPC] |
8813 |
0.0214 |
| 102 |
Cephalosporin Antibacterial [EPC] |
179 |
0.0211 |
| 103 |
Folate Analog [EPC] |
1048 |
0.0211 |
| 104 |
Poly(ADP-Ribose) Polymerase Inhibitor [EPC] |
438 |
0.0211 |
| 105 |
Vitamin A [EPC] |
1069 |
0.0210 |
| 106 |
Human Blood Coagulation Factor [EPC] |
7 |
0.0210 |
| 107 |
Cholinesterase Inhibitor [EPC] |
394 |
0.0209 |
| 108 |
Methylxanthine [EPC] |
1204 |
0.0208 |
| 109 |
Partial Opioid Agonist/Antagonist [EPC] |
1 |
0.0208 |
| 110 |
Xanthine Oxidase Inhibitor [EPC] |
3556 |
0.0208 |
| 111 |
alpha-Glucosidase Inhibitor [EPC] |
98 |
0.0205 |
| 112 |
Proton Pump Inhibitor [EPC] |
11833 |
0.0204 |
| 113 |
gamma-Aminobutyric Acid-ergic Agonist [EPC] |
1803 |
0.0204 |
| 114 |
Gamma Secretase Inhibitor [EPC] |
17 |
0.0203 |
| 115 |
Thiazide-like Diuretic [EPC] |
860 |
0.0203 |
| 116 |
Methylating Agent [EPC] |
21 |
0.0203 |
| 117 |
Loop Diuretic [EPC] |
9107 |
0.0202 |
| 118 |
Dihydropyridine Calcium Channel Blocker [EPC] |
6514 |
0.0202 |
| 119 |
Serotonin and Norepinephrine Reuptake Inhibitor [EPC] |
71 |
0.0202 |
| 120 |
Antidote [EPC] |
1263 |
0.0200 |
| 121 |
Arteriolar Vasodilator [EPC] |
1544 |
0.0199 |
| 122 |
Isocitrate Dehydrogenase 1 Inhibitor [EPC] |
41 |
0.0199 |
| 123 |
Enzyme Stabilizer [EPC] |
23 |
0.0199 |
| 124 |
Potassium Channel Blocker [EPC] |
1415 |
0.0198 |
| 125 |
Pyridone [EPC] |
799 |
0.0197 |
| 126 |
Bile Acid [EPC] |
441 |
0.0197 |
| 127 |
Histone Deacetylase Inhibitor [EPC] |
74 |
0.0197 |
| 128 |
Ester Local Anesthetic [EPC] |
957 |
0.0195 |
| 129 |
Peroxisome Proliferator Receptor alpha Agonist [EPC] |
1167 |
0.0195 |
| 130 |
Dietary Cholesterol Absorption Inhibitor [EPC] |
1729 |
0.0192 |
| 131 |
Fluoroquinolone Antibacterial [EPC] |
2443 |
0.0191 |
| 132 |
Serotonin Reuptake Inhibitor [EPC] |
1677 |
0.0189 |
| 133 |
Sulfonamide Antibacterial [EPC] |
74 |
0.0188 |
| 134 |
Monoamine Oxidase Inhibitor [EPC] |
57 |
0.0188 |
| 135 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1773 |
0.0187 |
| 136 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
23896 |
0.0185 |
| 137 |
alpha-Adrenergic Blocker [EPC] |
2559 |
0.0185 |
| 138 |
Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
454 |
0.0183 |
| 139 |
Azole Antifungal [EPC] |
2830 |
0.0183 |
| 140 |
Polyene Antifungal [EPC] |
767 |
0.0183 |
| 141 |
Parathyroid Hormone-Related Peptide Analog [EPC] |
535 |
0.0183 |
| 142 |
beta-Adrenergic Blocker [EPC] |
5499 |
0.0182 |
| 143 |
Benzothiazole [EPC] |
39 |
0.0180 |
| 144 |
Glucosylceramide Synthase Inhibitor [EPC] |
49 |
0.0178 |
| 145 |
Typical Antipsychotic [EPC] |
440 |
0.0178 |
| 146 |
Amide Local Anesthetic [EPC] |
1520 |
0.0178 |
| 147 |
Somatostatin Analog [EPC] |
118 |
0.0175 |
| 148 |
Ergot Derivative [EPC] |
84 |
0.0174 |
| 149 |
Vitamin B6 Analog [EPC] |
6 |
0.0173 |
| 150 |
Aldosterone Antagonist [EPC] |
2632 |
0.0172 |
| 151 |
CD38-directed Cytolytic Antibody [EPC] |
146 |
0.0172 |
| 152 |
SLAMF7-directed Immunostimulatory Antibody [EPC] |
88 |
0.0171 |
| 153 |
Tricyclic Antidepressant [EPC] |
8 |
0.0169 |
| 154 |
Antiarrhythmic [EPC] |
1631 |
0.0167 |
| 155 |
Vitamin B12 [EPC] |
5231 |
0.0163 |
| 156 |
HER2/neu Receptor Antagonist [EPC] |
1264 |
0.0163 |
| 157 |
Melanin Synthesis Inhibitor [EPC] |
18 |
0.0160 |
| 158 |
Vitamin D [EPC] |
4784 |
0.0160 |
| 159 |
Vasopressin Receptor Agonist [EPC] |
5 |
0.0160 |
| 160 |
Androgen [EPC] |
428 |
0.0159 |
| 161 |
Dipeptidyl Peptidase 4 Inhibitor [EPC] |
499 |
0.0157 |
| 162 |
Hepatitis C Virus NS5A Inhibitor [EPC] |
741 |
0.0155 |
| 163 |
Nucleoside Metabolic Inhibitor [EPC] |
4171 |
0.0154 |
| 164 |
beta Lactamase Inhibitor [EPC] |
69 |
0.0153 |
| 165 |
Glinide [EPC] |
133 |
0.0152 |
| 166 |
Antiprotozoal [EPC] |
126 |
0.0152 |
| 167 |
Antihypoglycemic Agent [EPC] |
63 |
0.0151 |
| 168 |
5-alpha Reductase Inhibitor [EPC] |
1512 |
0.0150 |
| 169 |
Cardiac Glycoside [EPC] |
1072 |
0.0150 |
| 170 |
Platinum-based Drug [EPC] |
3996 |
0.0150 |
| 171 |
Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] |
243 |
0.0150 |
| 172 |
Alkaloid [EPC] |
392 |
0.0149 |
| 173 |
Corticosteroid [EPC] |
19011 |
0.0149 |
| 174 |
Phosphodiesterase 3 Inhibitor [EPC] |
113 |
0.0148 |
| 175 |
Sympathomimetic-like Agent [EPC] |
475 |
0.0148 |
| 176 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
1529 |
0.0148 |
| 177 |
Central Nervous System Stimulant [EPC] |
1325 |
0.0147 |
| 178 |
Histamine-2 Receptor Antagonist [EPC] |
4761 |
0.0147 |
| 179 |
Angiotensin Converting Enzyme Inhibitor [EPC] |
1927 |
0.0143 |
| 180 |
Ileal Bile Acid Transporter Inhibitor [EPC] |
5 |
0.0143 |
| 181 |
Erythropoiesis-stimulating Agent [EPC] |
764 |
0.0143 |
| 182 |
Programmed Death Receptor-1 Blocking Antibody [EPC] |
3404 |
0.0142 |
| 183 |
Microtubule Inhibitor [EPC] |
2291 |
0.0141 |
| 184 |
Tetracycline-class Drug [EPC] |
978 |
0.0141 |
| 185 |
CD3-directed Antibody [EPC] |
8 |
0.0141 |
| 186 |
BCL-2 Inhibitor [EPC] |
865 |
0.0141 |
| 187 |
Prostacycline Vasodilator [EPC] |
1908 |
0.0141 |
| 188 |
Macrolide Antimicrobial [EPC] |
726 |
0.0140 |
| 189 |
Atypical Antipsychotic [EPC] |
7316 |
0.0139 |
| 190 |
Adrenocorticotropic Hormone [EPC] |
50 |
0.0139 |
| 191 |
4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] |
13 |
0.0137 |
| 192 |
Hematopoietic Stem Cell Mobilizer [EPC] |
20 |
0.0137 |
| 193 |
Vascular Endothelial Growth Factor Inhibitor [EPC] |
2494 |
0.0137 |
| 194 |
Aminosalicylate [EPC] |
1796 |
0.0136 |
| 195 |
Interferon alpha [EPC] |
729 |
0.0136 |
| 196 |
Anti-anginal [EPC] |
140 |
0.0135 |
| 197 |
CD30-directed Immunoconjugate [EPC] |
137 |
0.0134 |
| 198 |
Mood Stabilizer [EPC] |
2897 |
0.0134 |
| 199 |
Sodium Channel Blocker [EPC] |
17 |
0.0133 |
| 200 |
Nucleoside Analog Antiviral [EPC] |
1131 |
0.0133 |
| 201 |
Vasopressin V2 Receptor Antagonist [EPC] |
191 |
0.0132 |
| 202 |
Thyroid Hormone Synthesis Inhibitor [EPC] |
126 |
0.0132 |
| 203 |
Opioid Antagonist [EPC] |
12 |
0.0129 |
| 204 |
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] |
665 |
0.0127 |
| 205 |
Estrogen [EPC] |
2357 |
0.0127 |
| 206 |
Insulin [EPC] |
638 |
0.0125 |
| 207 |
Sulfone [EPC] |
133 |
0.0125 |
| 208 |
P2Y12 Platelet Inhibitor [EPC] |
1470 |
0.0125 |
| 209 |
Antimalarial [EPC] |
127 |
0.0123 |
| 210 |
Calcitonin Gene-related Peptide Antagonist [EPC] |
111 |
0.0123 |
| 211 |
Lead Chelator [EPC] |
1 |
0.0122 |
| 212 |
Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] |
39 |
0.0122 |
| 213 |
Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] |
69 |
0.0122 |
| 214 |
Angiotensin 2 Receptor Blocker [EPC] |
3878 |
0.0122 |
| 215 |
CD52-directed Cytolytic Antibody [EPC] |
233 |
0.0121 |
| 216 |
Blood Viscosity Reducer [EPC] |
52 |
0.0121 |
| 217 |
Human Immunoglobulin G [EPC] |
251 |
0.0120 |
| 218 |
Recombinant Human Deoxyribonuclease 1 [EPC] |
232 |
0.0119 |
| 219 |
Endoglycosidase [EPC] |
122 |
0.0119 |
| 220 |
Autologous Cellular Immunotherapy [EPC] |
69 |
0.0119 |
| 221 |
Dihydrofolate Reductase Inhibitor Antimalarial [EPC] |
15 |
0.0119 |
| 222 |
Integrin Receptor Antagonist [EPC] |
3151 |
0.0118 |
| 223 |
Pyruvate Kinase Activator [EPC] |
12 |
0.0118 |
| 224 |
Macrolide Antibacterial [EPC] |
28 |
0.0117 |
| 225 |
Melatonin Receptor Agonist [EPC] |
152 |
0.0116 |
| 226 |
Prostaglandin Analog [EPC] |
1066 |
0.0116 |
| 227 |
Phosphodiesterase 5 Inhibitor [EPC] |
1528 |
0.0114 |
| 228 |
Antiseptic [EPC] |
49 |
0.0114 |
| 229 |
Endothelin Receptor Antagonist [EPC] |
2251 |
0.0114 |
| 230 |
Lymphocyte Growth Factor [EPC] |
14 |
0.0114 |
| 231 |
Medium-chain Triglyceride [EPC] |
6 |
0.0114 |
| 232 |
Insulin Analog [EPC] |
5048 |
0.0113 |
| 233 |
gamma-Aminobutyric Acid A Receptor Agonist [EPC] |
18 |
0.0113 |
| 234 |
Photoenhancer [EPC] |
44 |
0.0113 |
| 235 |
Epidermal Growth Factor Receptor Antagonist [EPC] |
522 |
0.0113 |
| 236 |
RANK Ligand Inhibitor [EPC] |
2274 |
0.0113 |
| 237 |
Catecholamine [EPC] |
908 |
0.0113 |
| 238 |
Anti-epileptic Agent [EPC] |
2608 |
0.0113 |
| 239 |
Thrombopoietin Receptor Agonist [EPC] |
168 |
0.0112 |
| 240 |
Leukocyte Growth Factor [EPC] |
1571 |
0.0112 |
| 241 |
Janus Kinase Inhibitor [EPC] |
1863 |
0.0111 |
| 242 |
Rifamycin Antibacterial [EPC] |
388 |
0.0110 |
| 243 |
Pyrimidine Synthesis Inhibitor [EPC] |
492 |
0.0109 |
| 244 |
Nitrogen Binding Agent [EPC] |
1 |
0.0109 |
| 245 |
Lipid Emulsion [EPC] |
28 |
0.0108 |
| 246 |
Alkylating Drug [EPC] |
2516 |
0.0104 |
| 247 |
Purine Antimetabolite [EPC] |
1013 |
0.0104 |
| 248 |
Partial Opioid Agonist [EPC] |
968 |
0.0104 |
| 249 |
Cholinergic Nicotinic Agonist [EPC] |
628 |
0.0104 |
| 250 |
CTLA-4-directed Blocking Antibody [EPC] |
485 |
0.0103 |
| 251 |
Topoisomerase Inhibitor [EPC] |
785 |
0.0103 |
| 252 |
Hypoxia-inducible Factor Inhibitor [EPC] |
16 |
0.0102 |
| 253 |
Sigma-1 Agonist [EPC] |
88 |
0.0101 |
| 254 |
Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC] |
30 |
0.0101 |
| 255 |
Interferon alfa-2b [EPC] |
18 |
0.0101 |
| 256 |
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] |
172 |
0.0101 |
| 257 |
Actinomycin [EPC] |
22 |
0.0101 |
| 258 |
Quinolone Antimicrobial [EPC] |
95 |
0.0098 |
| 259 |
Gonadotropin [EPC] |
19 |
0.0097 |
| 260 |
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] |
1 |
0.0097 |
| 261 |
Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] |
60 |
0.0096 |
| 262 |
Leptin Analog [EPC] |
12 |
0.0096 |
| 263 |
Antifibrinolytic Agent [EPC] |
91 |
0.0095 |
| 264 |
Anthelmintic [EPC] |
27 |
0.0094 |
| 265 |
Hemoglobin S Polymerization Inhibitor [EPC] |
207 |
0.0093 |
| 266 |
Pyrethroid [EPC] |
16 |
0.0092 |
| 267 |
Antimycobacterial [EPC] |
217 |
0.0090 |
| 268 |
Factor Xa Inhibitor [EPC] |
2457 |
0.0090 |
| 269 |
CD20-directed Cytolytic Antibody [EPC] |
2941 |
0.0089 |
| 270 |
Aldehyde Dehydrogenase Inhibitor [EPC] |
10 |
0.0089 |
| 271 |
Orexin Receptor Antagonist [EPC] |
161 |
0.0089 |
| 272 |
Estrogen Agonist/Antagonist [EPC] |
23 |
0.0088 |
| 273 |
Asparagine-specific Enzyme [EPC] |
115 |
0.0087 |
| 274 |
Allylamine Antifungal [EPC] |
61 |
0.0086 |
| 275 |
Interleukin-6 Receptor Antagonist [EPC] |
1154 |
0.0085 |
| 276 |
Claudin 18.2-directed Cytolytic Antibody [EPC] |
11 |
0.0085 |
| 277 |
Sphingosine 1-phosphate Receptor Modulator [EPC] |
116 |
0.0085 |
| 278 |
Benzodiazepine Antagonist [EPC] |
7 |
0.0082 |
| 279 |
Dopamine and Norepinephrine Reuptake Inhibitor [EPC] |
31 |
0.0082 |
| 280 |
CD22-directed Immunoconjugate [EPC] |
24 |
0.0082 |
| 281 |
Copper-containing Intrauterine Device [EPC] |
419 |
0.0081 |
| 282 |
Aminoglycoside Antibacterial [EPC] |
360 |
0.0081 |
| 283 |
Neurokinin 3 Receptor Antagonist [EPC] |
17 |
0.0080 |
| 284 |
5-Lipoxygenase Inhibitor [EPC] |
5 |
0.0078 |
| 285 |
Carbonic Anhydrase Inhibitor [EPC] |
156 |
0.0078 |
| 286 |
Reducing and Complexing Thiol [EPC] |
19 |
0.0078 |
| 287 |
Anti-coagulant [EPC] |
28 |
0.0076 |
| 288 |
Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] |
57 |
0.0076 |
| 289 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
73 |
0.0073 |
| 290 |
Complement Factor D Inhibitor [EPC] |
2 |
0.0073 |
| 291 |
Echinocandin Antifungal [EPC] |
58 |
0.0073 |
| 292 |
Antisense Oligonucleotide [EPC] |
87 |
0.0073 |
| 293 |
Vitamin D2 Analog [EPC] |
102 |
0.0072 |
| 294 |
Vitamin D Analog [EPC] |
128 |
0.0071 |
| 295 |
Cytomegalovirus pUL97 Kinase Inhibitor [EPC] |
17 |
0.0071 |
| 296 |
Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] |
93 |
0.0071 |
| 297 |
Programmed Death Ligand-1 Blocker [EPC] |
142 |
0.0070 |
| 298 |
Tubulin Inhibiting Agent [EPC] |
2 |
0.0070 |
| 299 |
Vesicular Monoamine Transporter 2 Inhibitor [EPC] |
51 |
0.0070 |
| 300 |
Calcineurin Inhibitor Immunosuppressant [EPC] |
866 |
0.0069 |
| 301 |
Folate Analog Metabolic Inhibitor [EPC] |
2993 |
0.0069 |
| 302 |
Semifluorinated Alkane [EPC] |
13 |
0.0068 |
| 303 |
Neuraminidase Inhibitor [EPC] |
17 |
0.0067 |
| 304 |
Cardiac Myosin Inhibitor [EPC] |
34 |
0.0067 |
| 305 |
CCR5 Co-receptor Antagonist [EPC] |
15 |
0.0066 |
| 306 |
Anthracycline Topoisomerase Inhibitor [EPC] |
15 |
0.0064 |
| 307 |
Oxazolidinone Antibacterial [EPC] |
190 |
0.0064 |
| 308 |
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] |
61 |
0.0064 |
| 309 |
Pediculicide [EPC] |
41 |
0.0063 |
| 310 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
309 |
0.0063 |
| 311 |
Penem Antibacterial [EPC] |
212 |
0.0063 |
| 312 |
Interleukin-5 Antagonist [EPC] |
316 |
0.0063 |
| 313 |
Interferon beta [EPC] |
1262 |
0.0062 |
| 314 |
Selective T Cell Costimulation Modulator [EPC] |
842 |
0.0061 |
| 315 |
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] |
13 |
0.0061 |
| 316 |
Oxytocic [EPC] |
18 |
0.0060 |
| 317 |
Antiparasitic [EPC] |
38 |
0.0060 |
| 318 |
CD19-directed Cytolytic Antibody [EPC] |
4 |
0.0059 |
| 319 |
CD123 Interaction [EPC] |
3 |
0.0058 |
| 320 |
alpha-1 Adrenergic Agonist [EPC] |
25 |
0.0057 |
| 321 |
CD4-directed Blocking Antibody [EPC] |
3 |
0.0056 |
| 322 |
Acetylcholine Release Inhibitor [EPC] |
532 |
0.0055 |
| 323 |
Glycopeptide Antibacterial [EPC] |
345 |
0.0053 |
| 324 |
Recombinant Human Growth Hormone [EPC] |
116 |
0.0053 |
| 325 |
Erythroid Maturation Agent [EPC] |
13 |
0.0053 |
| 326 |
Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] |
16 |
0.0051 |
| 327 |
Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
112 |
0.0051 |
| 328 |
Adrenal Steroid Synthesis Inhibitor [EPC] |
5 |
0.0051 |
| 329 |
Antirheumatic Agent [EPC] |
536 |
0.0051 |
| 330 |
Adenosine Receptor Agonist [EPC] |
37 |
0.0051 |
| 331 |
Tumor Necrosis Factor Blocker [EPC] |
4702 |
0.0050 |
| 332 |
Tyrosine Kinase 2 Inhibitor [EPC] |
14 |
0.0050 |
| 333 |
Lipid-based Polyene Antifungal [EPC] |
73 |
0.0049 |
| 334 |
Complement Inhibitor [EPC] |
336 |
0.0049 |
| 335 |
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] |
35 |
0.0048 |
| 336 |
Interferon gamma Blocker [EPC] |
1 |
0.0048 |
| 337 |
Anti-IgE [EPC] |
402 |
0.0047 |
| 338 |
Tetracycline-class Antibacterial [EPC] |
36 |
0.0047 |
| 339 |
Bispecific CD20-directed CD3 T Cell Engager [EPC] |
17 |
0.0047 |
| 340 |
Interleukin-23 Antagonist [EPC] |
1011 |
0.0046 |
| 341 |
Chemokine Receptor Type 4 Interaction [EPC] |
6 |
0.0046 |
| 342 |
Sclerosing Agent [EPC] |
2 |
0.0045 |
| 343 |
Interleukin-2 Receptor Blocking Antibody [EPC] |
53 |
0.0045 |
| 344 |
Plasma Kallikrein Inhibitor [EPC] |
10 |
0.0045 |
| 345 |
Neuroactive Steroid Gamma-Aminobutyric Acid A Receptor Positive Modulator [EPC] |
10 |
0.0045 |
| 346 |
Neonatal Fc Receptor Blocker [EPC] |
23 |
0.0044 |
| 347 |
Phosphodiesterase 4 Inhibitor [EPC] |
712 |
0.0044 |
| 348 |
Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] |
14 |
0.0042 |
| 349 |
Lymphocyte Activation Gene-3 Blocker [EPC] |
2 |
0.0042 |
| 350 |
Antimetabolite Immunosuppressant [EPC] |
86 |
0.0042 |
| 351 |
Paramagnetic Contrast Agent [EPC] |
19 |
0.0042 |
| 352 |
Interleukin-12 Antagonist [EPC] |
425 |
0.0042 |
| 353 |
CD33-directed Immunoconjugate [EPC] |
15 |
0.0041 |
| 354 |
Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] |
70 |
0.0041 |
| 355 |
Rifamycin Antimycobacterial [EPC] |
14 |
0.0041 |
| 356 |
Interleukin-17 Receptor A Antagonist [EPC] |
8 |
0.0040 |
| 357 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
448 |
0.0040 |
| 358 |
General Anesthetic [EPC] |
168 |
0.0039 |
| 359 |
Thyroid Stimulating Hormone [EPC] |
4 |
0.0039 |
| 360 |
Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] |
63 |
0.0039 |
| 361 |
Complement 5a Receptor Antagonist [EPC] |
24 |
0.0038 |
| 362 |
PCSK9 Inhibitor [EPC] |
683 |
0.0037 |
| 363 |
Diagnostic Dye [EPC] |
1 |
0.0036 |
| 364 |
Interferon gamma [EPC] |
5 |
0.0036 |
| 365 |
Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] |
2 |
0.0034 |
| 366 |
Interleukin-17A Antagonist [EPC] |
667 |
0.0034 |
| 367 |
Vasoconstrictor [EPC] |
1 |
0.0034 |
| 368 |
Radioligand Therapeutic Agent [EPC] |
44 |
0.0034 |
| 369 |
Protease Inhibitor [EPC] |
148 |
0.0033 |
| 370 |
Interleukin-1 Receptor Antagonist [EPC] |
55 |
0.0033 |
| 371 |
Interleukin-6 Antagonist [EPC] |
2 |
0.0032 |
| 372 |
Radiographic Contrast Agent [EPC] |
79 |
0.0031 |
| 373 |
Progestin [EPC] |
855 |
0.0031 |
| 374 |
Cytochrome P450 3A Inhibitor [EPC] |
177 |
0.0029 |
| 375 |
Ectoparasiticide [EPC] |
9 |
0.0029 |
| 376 |
Type I Interferon Receptor Antagonist [EPC] |
5 |
0.0029 |
| 377 |
Uric Acid-specific Enzyme [EPC] |
10 |
0.0027 |
| 378 |
Thymic Stromal Lymphopoietin Blocker [EPC] |
17 |
0.0027 |
| 379 |
Interleukin-36 Receptor Antagonist [EPC] |
1 |
0.0027 |
| 380 |
Monobactam Antibacterial [EPC] |
7 |
0.0026 |
| 381 |
Mucocutaneous Epithelial Cell Growth Factor [EPC] |
1 |
0.0026 |
| 382 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
59 |
0.0025 |
| 383 |
Radioactive Diagnostic Agent [EPC] |
7 |
0.0024 |
| 384 |
Lipopeptide Antibacterial [EPC] |
22 |
0.0024 |
| 385 |
Interleukin-13 Antagonist [EPC] |
19 |
0.0024 |
| 386 |
Interleukin-4 Receptor alpha Antagonist [EPC] |
1119 |
0.0023 |
| 387 |
Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] |
4 |
0.0023 |
| 388 |
Prostacycline [EPC] |
2 |
0.0022 |
| 389 |
CD19-directed Chimeric Antigen Receptor [EPC] |
31 |
0.0022 |
| 390 |
Interleukin-5 Receptor alpha-directed Cytolytic Antibody [EPC] |
39 |
0.0020 |
| 391 |
Aryl Hydrocarbon Receptor Agonist [EPC] |
3 |
0.0017 |
| 392 |
Phenylalanine Metabolizing Enzyme [EPC] |
13 |
0.0016 |
| 393 |
SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] |
21 |
0.0016 |
| 394 |
Retinoid [EPC] |
361 |
0.0015 |
| 395 |
Selectin Blocker [EPC] |
2 |
0.0014 |
| 396 |
Gadolinium-based Contrast Agent [EPC] |
6 |
0.0012 |
| 397 |
Amyloid Beta-directed Antibody [EPC] |
4 |
0.0011 |
| 398 |
Selective T Cell Costimulation Blocker [EPC] |
5 |
0.0011 |
| 399 |
Interleukin-31 Receptor alpha Antagonist [EPC] |
13 |
0.0010 |
| 400 |
Recombinant Human Nerve Growth Factor [EPC] |
9 |
0.0007 |
| 401 |
Nucleoside Analog Antifungal [EPC] |
1 |
0.0007 |
| 402 |
Humanized Monoclonal Antibody Fragment [EPC] |
1 |
0.0007 |
| 403 |
Contrast Agent for Ultrasound Imaging [EPC] |
5 |
0.0007 |
| 404 |
Skin Test Antigen [EPC] |
1 |
0.0005 |
| 405 |
TRPM8 Thermoreceptor Agonist [EPC] |
2 |
0.0005 |